Skip to content

Author

N. Desai

We have 3 of 41 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Lipoprotein(a) and statin indications in low-risk patients based on the 2026 ACC/AHA dyslipidemia guideline

Background Though elevated lipoprotein (a) (Lp[a]) is associated with ASCVD and testing is recommended for all adults, how to use Lp(a) for decision-making in low-risk patients remains uncertain. Methods We studied low-risk adults in a large healthcare system, excluding those on statins or with statin indications in th...

K. F. Faridi, Qi-Fan Wu, E. Spatz et al. · 0 citations
Open access Sep 2026

Real-World Effectiveness of Evolocumab in Reducing Major Adverse Cardiovascular Events: A Cohort Study.

BACKGROUND Evolocumab reduces major adverse cardiovascular events in randomized trials, but evidence of its effectiveness in real-world clinical practice remains limited. METHODS US adults with atherosclerotic cardiovascular disease who initiated evolocumab between 2017 and 2023 were identified from the Komodo Health...

Ran Jin, K. Hurwitz, N. Dhalwani et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.